Investigating the clinical efficacy and mechanism of Runfei Huayu recipe in treating connective tissue disease merger interstitial lung disease based on Th17/Treg glycolytic pathway

Taizhou Hospital of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Meet the diagnostic criteria of traditional Chinese and western medicine for CTD-ILD;
•2. 35 years = age =75 years, male or female;
•3. This study was approved by the ethics committee of our hospital, and informed consent was obtained from patients with signed informed consent;
•4. No fertility requirement.

•1. Patients with pulmonary tuberculosis, chronic obstructive pulmonary disease, emphysema, bronchiectasis, lung tumors, silicosis, pneumoconiosis and other lung diseases;
•2. Patients with some serious primary diseases, such as digestive, respiratory, cardiovascular, hematopoietic and nervous system diseases, mental diseases, etc.;
•3. Abnormal liver and kidney function, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) exceeding 1.5 times the normal value, blood creatinine (Scr) and urea nitrogen (BUN) any higher than the normal value;
•4. Allergic constitution and allergic to clinical study medication;
•5. Women who are during pregnancy, preparing for pregnancy, or during breastfeeding period.

发起方

Taizhou Hospital of traditional Chinese Medicine